SCHEMBL2385156

SCHEMBL2385156

CC(=O)c1cc(-c2cc(Cl)ccn2)cs1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALAD P13716 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
POLB P06746 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAP4K4 O95819 1/20 0.40
MAPT P10636 2/20 0.39
ALDH1A1 P00352 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TP53 P04637 1/20 0.39
KDR P35968 2/20 0.37
KDM4C Q9H3R0 1/20 0.37
IKBKE Q14164 1/20 0.37
AURKB Q96GD4 1/20 0.37
TBK1 Q9UHD2 1/20 0.37
ABL1 P00519 1/20 0.36
PIM1 P11309 1/20 0.36
KMO O15229 1/20 0.35
ALOX5 P09917 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24638508 0.81 IKBKE (0.38) ALADNPC1RAB9APOLBSMN1; SMN2
SCHEMBL15177354 0.74 ALAD (0.72) ALADNPC1RAB9APOLBSMN1; SMN2
SCHEMBL2384472 0.74 PIM1 (0.38) MAP4K4MAPTALDH1A1L3MBTL1PIM1
SCHEMBL2385102 0.73 KDM4C (0.37) NPC1RAB9AMAP4K4MAPTALDH1A1
SCHEMBL2382865 0.73 PIM1 (0.36) NPC1RAB9AMAP4K4MAPTALDH1A1
SCHEMBL899382 0.73 MAPT (0.59) NPC1RAB9APOLBSMN1; SMN2MAPT
SCHEMBL2382655 0.71 PIM1 (0.38) NPC1RAB9ASMN1; SMN2MAP4K4MAPT
SCHEMBL1665488 0.69
SCHEMBL10875927 0.69 ALDH1A1 (0.49) NPC1RAB9APOLBSMN1; SMN2MAPT
SCHEMBL34469643 0.69 ALAD (0.43) ALADNPC1RAB9ASMN1; SMN2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022209-B2 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor JANSSEN PHARMACEUTICA NV (BE) 2011-09-20 US disclosed
WO-2009035671-A1 SUBSTITUTED NITROGEN-CONTAINING HETEROARYL DERIVATIVES USEFUL AS MODULATORS OF THE HISTAMINE H4 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2009-03-19 WO disclosed
US-20090069305-A1 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor JANSSEN PHARMACEUTICA N.V. (BE) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069305-A1 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor HRH4, HRH3, HRH2 ALAD 4605/4885NPC1 1747/4885RAB9A 1615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.